Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Lymphir™ (Denileukin Diftitox-Cxdl) Added to National Comprehensive Cancer Network (Nccn) Clinical Practice Guidelines in Oncology
Citius Pharmaceuticals, Inc.和Citius Oncology, Inc.宣布Lymphir™ (Denileukin Diftitox-Cxdl)被添加到国家综合癌症网络(NCCN)肿瘤临床实践指南